Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trial.

Camilla Fuchs Andersen,Massar Omar,Andreas Glenthøj,Daniel El Fassi,Holger J Møller,Jørgen A Lindholm Kurtzhals,Bjarne Styrishave,Caroline Kistorp,Christian Tuxen,Mikael K Poulsen,Jens Faber,Lars Køber,Finn Gustafsson,Jacob E Møller,Morten Schou,Jesper Jensen

European journal of heart failure（2023）

引用 18|浏览34

暂无评分

摘要

These findings suggest that empagliflozin increases erythropoiesis and augments early iron utilization in patients with HFrEF. These mechanisms may contribute to the cardioprotective properties of empagliflozin.

查看译文

关键词

Erythropoiesis,Heart failure,Pharmacotherapy,SGLT2 inhibitor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要